Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2001-08-31
2004-04-13
Bockelman, Mark (Department: 3762)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S123000
Reexamination Certificate
active
06721598
ABSTRACT:
FIELD OF THE INVENTION
The present invention generally relates to an implantable cardiac stimulation system and lead and more particularly to such a system and lead for sensing electrical activity of the right and left heart and delivering stimulation pulses to the right and left heart. The lead is implantable in the coronary sinus region of the heart.
BACKGROUND OF THE INVENTION
Implantable cardiac stimulation devices are well known in the art. Such devices may include, for example, implantable cardiac pacemakers and defibrillators. The devices are generally implanted in a pectoral region of the chest beneath the skin of a patient within what is known as a subcutaneous pocket. The implantable devices generally function in association with one or more electrode carrying leads which are implanted within the heart. The electrodes are usually positioned within the right side of the heart, either within the right ventricle or right atrium, or both, for making electrical contact with their respective heart chamber. Conductors within the leads and a proximal connector carried by the leads couple the electrodes to the device to enable the device to sense cardiac electrical activity and deliver the desired therapy.
Traditionally, therapy delivery had been limited to the venous, or right side of the heart. The reason for this is that implanted electrodes can cause blood clot formation in some patients. If a blood clot were released arterially from the left heart, as for example the left ventricle, it could pass directly to the brain potentially resulting in a paralyzing or fatal stroke. However, a blood clot released from the right heart, as from the right ventricle, would pass into the lungs where the filtering action of the lungs would prevent a fatal or debilitating embolism in the brain.
Recently, new lead structures and methods have been proposed and even practiced for delivering cardiac rhythm management therapy to the left heart. These lead structures and methods avoid direct electrode placement within the left atrium and left ventricle of the heart by lead implantation within the coronary sinus region of the heart. As used herein, the phrase “coronary sinus region” refers to the venous vasculature of the left ventricle, including any portions of the coronary sinus, great cardiac vein, left marginal vein, left posterior ventricular vein, middle cardiac vein, and/or small cardiac vein or any other cardiac vein accessible by the coronary sinus.
It has been demonstrated that electrodes placed in the coronary sinus region of the heart may be used for left atrial pacing, left ventricular pacing, or cardioversion and defibrillation. These advancements enable implantable cardiac stimulation devices to address the needs of a patient population with left ventricular dysfunction and/or congestive heart failure which would benefit from left heart side pacing, either alone or in conjunction with right heart side pacing (bi-chamber pacing), and/or defibrillation.
Universal pacing and/or defibrillation systems capable of pacing and/or defibrillating all of the chambers of the right and left heart would of course require numerous pacing and/or defibrillation electrodes to be employed within the heart and its coronary venous system. Providing the numerous electrodes to implement such universal heart stimulation systems would in turn require an inordinate number of leads if currently available right and left heart leads were employed. This would result in unduly long implant procedures and possibly more leads than the human anatomy is able to accommodate. The number of leads required may also make it difficult to accurately locate each electrode at its most efficacious position within the heart.
Hence, there is a need in the art for new and improved right and left heart leads and lead configurations which provide efficient left heart access and integrated right and left heart therapies. Electrode placement on the leads should enable effective therapy and electrode selection to accommodate differences in heart physiology from one patient to another. Universal pacing and defibrillation systems that would result from the new and improved leads and lead configurations could provide significant improved therapies. Coordinated right heart and left heart pacing therapies would be made possible. Further, improved defibrillation therapies would also be made possible. The therapies could provide improved electrode configuration selection for improved defibrillation energy distribution within the heart or support improved sequential defibrillation pulse techniques. The present invention is directed to left heart leads and right and left heart lead configurations which address the above mentioned needs.
SUMMARY OF THE INVENTION
The invention provides an implantable cardiac lead for implant in the coronary sinus of a heart and for use with an implantable cardiac stimulation device for sensing electrical activity of the right and left heart and delivering stimulation pulses to the right and left heart. The lead includes a proximal connector, a lead body including a plurality of conductors coupled to the proximal connector and insulating the plurality of conductors, a left ventricular pacing electrode for placement in electrical contact with the left ventricle, a left ventricular defibrillation electrode for placement in electrical contact with the left ventricle, a left atrial pacing electrode for placement in electrical contact with the left atrium, a left atrial defibrillation electrode for placement in electrical contact with the left atrium, and a right atrial pacing electrode for placement in electrical contact with the right atrium.
In accordance with further aspects of the invention, the lead may include a right atrial defibrillation electrode for placement in one of the right atrium and superior vena cava. The defibrillation electrodes may be coil electrodes.
In accordance with further features of the invention, the right atrial pacing electrode of the lead is preferably positioned on the lead body so that when the left ventricular pacing electrode is adjacent the left ventricle within the coronary sinus of the heart, the right atrial pacing electrode is within the coronary sinus adjacent to the ostium of coronary sinus.
The invention further provides an implantable cardiac stimulation system capable of sensing electrical activity of the right and left heart and delivering stimulation pulses to the right and left heart. The system includes a single cardiac lead. The lead includes a left ventricular pacing electrode for placement in electrical contact with the left ventricle, a left ventricular defibrillation electrode for placement in electrical contact with the left ventricle, a left atrial pacing electrode for placement in electrical contact with the left atrium, a left atrial defibrillation electrode for placement in electrical contact with the left atrium, and a right atrial pacing electrode for placement in electrical contact with the right atrium. The system further includes a cardiac stimulation device including a pulse generator for delivering pacing pulses to any combination of the pacing electrodes, delivering defibrillation pulses to any combination of the defibrillation electrodes, and sensing electrical activity with any combination of the pacing electrodes.
REFERENCES:
patent: 4548203 (1985-10-01), Tacker, Jr. et al.
patent: 4932407 (1990-06-01), Williams
patent: 5111811 (1992-05-01), Smits
patent: 5174289 (1992-12-01), Cohen
patent: 5235978 (1993-08-01), Hirschberg et al.
patent: 5267560 (1993-12-01), Cohen
patent: 5314430 (1994-05-01), Bardy
patent: 5350404 (1994-09-01), Adams et al.
patent: 5366494 (1994-11-01), Holleman et al.
patent: 5411524 (1995-05-01), Rahul
patent: 5411529 (1995-05-01), Hudrlik
patent: 5423865 (1995-06-01), Bowald et al.
patent: 5431683 (1995-07-01), Bowald et al.
patent: 5466254 (1995-11-01), Helland
patent: 5531764 (1996-07-01), Adams et al.
patent: 5545204 (1996-08-01), Cammilli et al.
patent: 5662697 (1997-09-01), Li et al.
patent: 5720768 (1998-02-01), V
Bornzin Gene A.
Falkenberg Eric
Helland John R.
Bockelman Mark
Pacesetter Inc.
LandOfFree
Coronary sinus cardiac lead for stimulating and sensing in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Coronary sinus cardiac lead for stimulating and sensing in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coronary sinus cardiac lead for stimulating and sensing in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3209556